Get 40% Off
🤯 This Tech Portfolio is up 29% YTD! Join Now to Get April’s Top PicksGet The Picks – Just 99 USD

Boyu, Hillhouse, others vie for HK-based medical device firm Quasar -sources

Published 05/24/2023, 11:56 PM
Updated 05/25/2023, 12:01 AM
© Reuters. FILE PHOTO: The logo of Boyu Capital is seen at the company's office in Hong Kong, Dec. 11, 2013. REUTERS/Tyrone Siu

© Reuters. FILE PHOTO: The logo of Boyu Capital is seen at the company's office in Hong Kong, Dec. 11, 2013. REUTERS/Tyrone Siu

By Kane Wu and Yantoultra Ngui

HONG KONG (Reuters) - Private equity firms Boyu Capital, Hillhouse Capital and BPEA EQT (NYSE:EQT) are among bidders vying for Longreach Group's Hong Kong-based medical device maker Quasar, three people with knowledge of the matter said.

Longreach, an Asia-focused private equity firm, is targeting a valuation of as much as $600 million or more for the entire company, said one of the three sources and a separate person with knowledge of the transaction.

The bidding process, which is being run by Goldman Sachs (NYSE:GS), has entered the second round, the first three sources said.

All the sources declined to be identified as the deal talks are confidential.

Longreach, Quasar, Boyu and Hillhouse did not respond to a request for comment. BPEA EQT and Goldman declined to comment.

Bidders are currently doing due diligence on the company, according to two of the sources, one of whom added that final bids are due by end of June.

Private equity firm General Atlantic and a number of strategic buyers are also in the fray, said the fourth source and two separate people with knowledge of the matter. General Atlantic declined to comment.

The sale process comes at a time where medical services companies are gaining favour, as investors bet on the healthcare sector's ability to weather the challenging global economic environment.

Established in 1988 in Israel, Quasar is a global contract development and manufacturing organization (CDMO) of advanced medical devices and counts Johnson & Johnson (NYSE:JNJ) and Medtronic (NYSE:MDT) PLC as clients, according to the company's website.

It has two manufacturing facilities in China and one in Thailand, the website showed.

© Reuters. FILE PHOTO: The logo of Boyu Capital is seen at the company's office in Hong Kong, Dec. 11, 2013. REUTERS/Tyrone Siu

Longreach acquired a controlling stake in the company in 2019 for an undisclosed amount.

Quasar's earnings before interest, taxes, depreciation and amortization was about $30 million in 2022, said one of the sources and a seventh source with knowledge of the transaction.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.